Copyright
©The Author(s) 2023.
World J Exp Med. Sep 20, 2023; 13(4): 75-94
Published online Sep 20, 2023. doi: 10.5493/wjem.v13.i4.75
Published online Sep 20, 2023. doi: 10.5493/wjem.v13.i4.75
Figure 3 Flow-cytometry results of erythroblastosis virus E26 oncogene homolog 2 protein expression in a patient affected with Alzheimer disease.
A: R1: 78.1 % (7812/10000 cells); B: Erythroblastosis virus E26 oncogene homolog 2: 2.59 % (202/7812 cells). Ets2: Erythroblastosis virus E26 oncogene homolog 2; SSC: Side scatter reflects the internal complexity. Adapted from Reference[11].
- Citation: Mehdipour P, Fathi N, Nosratabadi M. Personalized clinical managements through exploring circulating neural cells and electroencephalography. World J Exp Med 2023; 13(4): 75-94
- URL: https://www.wjgnet.com/2220-315X/full/v13/i4/75.htm
- DOI: https://dx.doi.org/10.5493/wjem.v13.i4.75